Ciao

Siamo qui per aiutare i cittadini europei a capire cosa sono le cellule staminali.  Forniamo informazioni affidabili e indipendenti, nonché collaudate risorse didattiche sulle cellule staminali e il loro impatto sulla società.

Contenuti

Europe approves Holoclar®, the first stem cell-based medicinal product

The European Commission has given Holoclar®, the first advanced therapy medicinal product (ATMP) containing stem cells, conditional marketing authorisation following a recommendation for approval by the European Medicines Agency.

Stem cells in the classroom

Not many researchers go directly into schools to teach science lessons, but that’s what Professor Ian Chambers from the MRC Centre for Regenerative Medicine did when he teamed up with EuroStemCell science communicator Emma Kemp. They have just published an academic paper on their experience of bringing stem cell research into schools. Here’s what they learned.

Making insulin producing beta cells from stem cells – how close are we?

The unseen world: Insulin-producing cells made from human embryonic stem cellsThe unseen world: Insulin-producing cells made from human embryonic stem cells

Two recent studies have revealed for the first time how to to generate insulin producing cells, that resemble normal beta cells, in the lab from human pluripotent stem cells. This provides a step forward for a potential cell therapy treatment for diabetes. But how alike are these cells to the beta cells found in our bodies? How close are we to testing these cells in diabetics? And what other questions still remain? In this commentary, Henrik Semb tackles these questions providing perspective in this complex and challenging field.

Speranze senza iperbole: Storia delle cellule staminali dalla scoperta alla terapia

 Storia delle cellule staminali dalla scoperta alla terapia

Newsletter

Condividi contenuti